Skip to content

Clinical trials

Phase 3 Hepatic Encephalopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatic Encephalopathy Phase: Phase 3 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20051
20061
20072
20111
20131
20151
20181
20212
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Active, not recruiting2
Recruiting2
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.4
Aga Khan University2
A.O. Ospedale Papa Giovanni XXIII1
Cairo University1
Cristian Ichim1
Hunter Holmes Mcguire Veteran Affairs Medical Center1
King's College London1
Mallinckrodt1
NYU Langone Health1
Qianfoshan Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatic Encephalopathy17
Liver Cirrhosis4
Fibrosis3
Fatty Liver, Alcoholic1
Hepatic Insufficiency1
Hyponatremia1
Infections1
Liver Failure, Acute1
Non-alcoholic Fatty Liver Disease1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.